Skip to main content
Clinical Trials/IRCT20201129049534N6
IRCT20201129049534N6
Recruiting
Phase 2

Evaluation of the effect of selenium supplementation on sonographic findings of salivary glands and inflammatory factors and oxidative stress in patients with thyroid cancer treated with radioactive iodine

Esfahan University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Thyroid cancer.
Sponsor
Esfahan University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Ages 20 to 65
  • Diagnosis of thyroid cancer by imaging, such as ultrasound, computed tomography, magnetic resonance imaging, and positron tomography (PET) scan

Exclusion Criteria

  • History of sialadenitis (inflammation of the salivary glands)
  • Sjogren's history
  • History of collagen vascular disease involving the salivary glands.
  • History of any salivary gland surgery
  • Follow a special diet in the last 3 months
  • Pregnancy and lactation
  • Patient dissatisfaction to participate in the study
  • Taking dietary supplements in the last 3 months
  • Suffering from certain diseases such as diseases caused by congenital diseases, immune system defects, etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials